Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(10%)
Results Posted
0%(0 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
1
10%
Ph early_phase_1
1
10%
Ph phase_1
6
60%
Ph phase_2
2
20%

Phase Distribution

7

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 1Safety & dosage
6(60.0%)
Phase 2Efficacy & side effects
2(20.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(1)
Terminated(2)
Other(5)

Detailed Status

Suspended3
unknown2
Terminated1
Recruiting1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (10.0%)
Phase 16 (60.0%)
Phase 22 (20.0%)
N/A1 (10.0%)

Trials by Status

terminated110%
recruiting110%
withdrawn110%
unknown220%
not_yet_recruiting110%
completed110%
suspended330%

Recent Activity

1 active trials
Showing 5 of 10
recruitingphase_2

Safety and Potential Effect of Innovative Treatment by Adjuvant Injection of Stromal Vascular Fraction From Autologous Adipose Tissue of URethral Stenosis With Endoscopic Urethrotomy

NCT05857371
suspendedphase_1

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders

NCT02946658
suspendedphase_1

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease

NCT02952131
suspendedphase_1

Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)

NCT03909750
not_yet_recruitingphase_1

Safety and Potential Effect of Innovative Cell-based Therapy Using Adipose-derived Stromal Vascular Fraction in Patients With Autoimmune Xerostomia

NCT05857358
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT05857371Phase 2

Safety and Potential Effect of Innovative Treatment by Adjuvant Injection of Stromal Vascular Fraction From Autologous Adipose Tissue of URethral Stenosis With Endoscopic Urethrotomy

Recruiting
NCT02946658Phase 1

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders

Suspended
NCT02952131Phase 1

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease

Suspended
NCT03909750Phase 1

Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)

Suspended
NCT05857358Phase 1

Safety and Potential Effect of Innovative Cell-based Therapy Using Adipose-derived Stromal Vascular Fraction in Patients With Autoimmune Xerostomia

Not Yet Recruiting
NCT05279157Phase 2

Autologous Adipose-Derived Adult Stem Cell Implantation for Corneal Diseases (ADASCs-CT-CD)

Completed
NCT02987855Phase 1

Adipose Stem/Stromal Cells in RSD, CRPS, Fibromyalgia

Withdrawn
NCT03427905Not Applicable

Autologous Adipose-Derived Adult Stromal Vascular Cell Transplantation for Alopecia

Unknown
NCT02741362Phase 1

Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome

Terminated
NCT02932852Early Phase 1

Autologous Adipose-Derived Adult Stem Cell Transplantation for Corneal Diseases

Unknown

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10